The DOI matches its Crossref record.
Changes in Concentration of DNA in Serum and Plasma during Storage of Blood Samples
Abstract
Cell-free DNA in serum and plasma has been suggested to have diagnostic potential because associations between DNA concentrations and several disorders have been described (1). The concentration of cell-free DNA circulating in plasma and serum has been analyzed in several studies and used as an interchangeable index of the quantity of circulating DNA in blood (2)(3)(4). However, it is known that the DNA concentration in serum is ∼3- to 24-fold higher than in plasma (3)(4)(5)(6). Recently published articles in this journal showed that various preanalytical factors of blood sampling and processing can affect the DNA concentration in plasma (5)(7)(8), but these findings do not explain the difference between plasma and serum concentrations of DNA mentioned above. Comparative investigations of the preanalytical conditions influencing the DNA concentration in serum and plasma are lacking. In addition, reference intervals for the concentration of cell-free DNA in serum were established without considering these factors (9). Thus, to complement the data of Lui et al. (5), we analyzed the influence of time delay in blood processing for plasma and serum at room temperature and at 4 °C. Venous blood samples from 10 healthy volunteers (5 females and 5 males; mean age, 42 years) were simultaneously collected in Monovette plastic tubes without any additive for native serum (cat. no. 02.1726.001; Sarstedt), in plastic tubes with kaolin-coated plastic granulate coagulation accelerator (cat. no. 04.1904.001; Sarstedt) for preparation of serum samples, and in Monovette plastic tubes coated with potassium EDTA (cat. no. 05.1167.001; Sarstedt) for preparation of plasma samples. The tubes were either centrifuged at 2000g for 10 min at 4 °C immediately after venipuncture or were stored for 2, 4, or 8 h at room temperature (25 °C) and at 4 °C for 8 and 24 h, respectively, before being centrifuged under similar conditions. The supernatants were carefully removed and centrifuged again at 16 000g for 10 min at 4 °C and stored at −80 °C until analysis. Using a NucleoSpin Blood Kit (Macherey-Nagel), we extracted DNA from 400 μL of sample per column, eluted it in 100 μL of buffer according to the manufacturer’s instructions, and stored the eluted DNA at −20 °C until use. DNA equivalents were quantified by amplifying the β-globin gene by real-time PCR (LightCycler™ Roche), using the QuantiTect SYBR Green PCR Kit (Qiagen). A 110-bp fragment of the β-globin gene was generated with the forward primer 5′-ACACAACTGTGTTCACTAGC-3′ and the reverse primer 5′-CAACTTCATCCACGTTCACC-3′ (TIB MolBiol) in a final concentration of 0.5 μM each. The cycle conditions were as follows: initial activation step at 95 °C for 15 min, followed by 45 cycles of denaturation at 95 °C for 15 s, annealing at 56 °C for 20 s, and extension at 72 °C for 15 s. The reaction volume was 20 μL, including 2 μL of DNA eluate. The product-specific melting temperature was ∼82 °C. A calibration curve obtained with serial dilutions of a control DNA template (LightCycler Control Kit DNA; Roche) was linear at least up to 4546 genome-equivalents of β-globin [genome-equivalents/mL were calculated using a conversion factor of 6.6 pg of DNA per single diploid human cell (5)]. The within-run (n = 12) and between-run (n = 10) imprecisions (CVs) for a DNA template (807.6 genome-equivalents/mL) were 3.1% and 7.2%, respectively. Statistical analyses were made with GraphPad Prism 3.03 for Windows (GraphPad Software). Parametric statistical tests were used because the DNA concentrations in our 10 samples had a gaussian distribution (Kolmogorov–Smirnov test). There was no difference in the mean DNA concentrations (P = 0.729, paired t-test) in paired serum samples prepared with or without coagulation accelerator. We therefore compared the DNA concentrations in EDTA plasma with those in serum samples obtained in tubes without clot activation additive (Fig. 1 ). The DNA concentration in plasma did not change when blood samples were stored at room temperature for 8 h or at 4 °C for 24 h before being processed (Fig. 1 ). These results correspond to observations of Lui et al. (5), who analyzed the DNA concentrations during a 6-h interval after phlebotomy. Our data (Fig. 1 ) confirm the observation that the DNA concentration is higher in serum than in plasma, as also shown by others (3)(4)(5)(6). DNA concentrations in plasma (left) and serum (right) aliquots prepared from blood samples stored at room temperature or at 4 °C and processed at different time intervals after phlebotomy. Data are mean (SE; error bars) β-globin concentrations (genome-equivalents/mL) determined by real-time quantitative PCR in samples of each from the 10 healthy adult volunteers. The intervals between blood collection and centrifugation of samples after storage at room temperature (□) or 4 °C (▪) are indicated on the x axis. a and b indicate the significances, calculated by the Dunnett multiple-comparison test after parametric
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Self-citationCirculating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767
Circulating cell free DNA: Preanalytical considerations
El Messaoudi, S., Rolet, F., Mouliere, F., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 560
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
Umetani, N., Giuliano, A. E., Hiramatsu, S. H., Amersi, F., Nakagawa, T., Martino, S., & Hoon, D. S. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9493 · Cited by 351
Cell-free DNA in the blood as a solid tumor biomarker–a critical appraisal of the literature
Jung, K., Fleischhacker, M., & Rabien, A. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.07.032 · Cited by 337
Self-citationGorgannezhad, L., Umer, M., Islam, M. N., Nguyen, N.-T., & Shiddiky, M. J. A. (2018) · Lab on a Chip · doi:10.1039/c8lc00100f · Cited by 312
Beck, J., Bierau, S., Balzer, S., Andag, R., Kanzow, P., Schmitz, J., Gaedcke, J., Moerer, O., Slotta, J. E., Walson, P., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.210328 · Cited by 271
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Meddeb, R., Pisareva, E., & Thierry, A. R. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.298323 · Cited by 262
Postel, M., Roosen, A., Laurent-Puig, P., Taly, V., & Wang-Renault, S.-F. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1400384 · Cited by 254
Metadata
- Authors
- Jung, M., Klotzek, S., Lewandowski, M., Fleischhacker, M., & Jung, K.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 49
- Issue
- 6
- Pages
- 1028-1029
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2146207695
- Cited by
- 233
- References
- 0
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.